Lv2
130 积分 2022-06-27 加入
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
3小时前
已完结
Implementation of digital health technology in clinical trials: the 6R framework
1年前
已完结
Mitotic bookmarking by SWI/SNF subunits
1年前
已完结
How thought itself can drive tumour growth
1年前
已完结
Protein degraders enter the clinic — a new approach to cancer therapy
1年前
已完结
Rare molecular subtypes of lung cancer
1年前
已完结
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019
1年前
已完结
Emerging Strategies for the Treatment of Small Cell Lung Cancer
1年前
已完结
CCNE1 Amplification as a Therapeutic Target
1年前
已完结
Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level
1年前
已完结
皖公网安备34019202002308
